Volume 16, Issue 2 (8-2002)                   Med J Islam Repub Iran 2002 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
TORABI-NEZHAD S, AZARIAN A. DIFFERENTIATION BETWEEN BENIGN, REACTIVE AND MALIGNANT CELLS IN SEROSAL BODY FLUIDS BY AgNOR STAINING. Med J Islam Repub Iran 2002; 16 (2) :95-100
URL: http://mjiri.iums.ac.ir/article-1-759-en.html
DIFFERENTIATION BETWEEN BENIGN, REACTIVE AND MALIGNANT CELLS IN SEROSAL BODY FLUIDS BY AgNOR STAINING
S TORABI-NEZHAD , A AZARIAN
From the Department of Pathology, Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, I.R. Iran.
Abstract:   (3760 Views)
Argyrophilic nucleolar organizer regions (AgNORs) were determined in 94 pleural, pericardial and peritoneal effusions. The results were correlated with cytologic diagnosis to determine the diagnostic potential of this technique. Cytologically the number of normal, reactive and malignant effusions were 32, 28 and 34 respectively. The mean AgNOR counts for normal, reactive and malignant specimens were 1.365,2.328 and 4.747 respectively. The cut-off points between normal-reactive and reactive-malignant specimens were 1.84 and 3.53 respectively. All of the malignant specimens (100%) had AgNOR counts above 3.53. Neither reactive nor normal specimens had AgNOR counts above 3.53. 82.1 % of reactive specimens had AgNOR counts above 1.84 and 87.5% of normal specimens had AgNOR counts below this point. There was a statistically significant difference between the AgNOR counts in normal, reactive and malignant effusions (p<0.001). We conclude that the AgNOR method is a specific diagnostic tool for serosal cavity effusions, especially when malignancy is suspected.
Full-Text [PDF 772 kb]   (3788 Downloads)    
Type of Study: Original Research | Subject: Pathology
Add your comments about this article : Your username or Email:
CAPTCHA
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.